NCT03328143View on ClinicalTrials.gov

Feasibility of Aromatherapy in an Awake Craniotomy Environment

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 3, 2018

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions
Intracranial Pathology
Interventions
DRUG

Lavender (Lavandula angustifolia)

Lavender (Lavandula angustifolia) is an essential oil.

Trial Locations (1)

53215

Aurora Health Care, Aurora St. Luke's Medical Center, Milwaukee

All Listed Sponsors
lead

Wake Forest University Health Sciences

OTHER

NCT03328143 - Feasibility of Aromatherapy in an Awake Craniotomy Environment | Biotech Hunter | Biotech Hunter